The DOI matches its Crossref record; 43 of the 43 references it cites were found in a registry or an index.
Enhanced atherosclerosis and kidney dysfunction in eNOS–/–Apoe–/– mice are ameliorated by enalapril treatment
Open accessAbstract
Hypertension and atherosclerosis are each important causes of morbidity and mortality in the developed world. We have investigated the interaction between these conditions by breeding mice that are atherosclerotic due to lack of apolipoprotein (apo) E with mice that are hypertensive due to lack of endothelial nitric oxide synthase (eNOS). The doubly deficient mice (nnee) have higher blood pressure (BP) and increased atherosclerotic lesion size but no change in plasma lipoprotein profiles compared with normotensive but atherosclerotic (NNee) mice. The nnee mice also develop kidney damage, evidenced by increased plasma creatinine, decreased kidney weight/body weight ratio, and glomerular lipid deposition and calcification. Enalapril treatment abolishes the deleterious effects of eNOS deficiency on BP, atherosclerosis, and kidney dysfunction in nnee mice. In striking contrast, a genetic lack of inducible NOS, which does not affect BP, has no effect on the development of atherosclerotic lesions in Apoe(-/-) mice. We also observed a positive relationship between BP and size of atherosclerotic lesions These results suggest that the atherogenic effects of eNOS deficiency can be partially explained by an increase in BP and reemphasize the importance of controlling hypertension in preventing atherosclerosis.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The pathogenesis of atherosclerosis: a perspective for the 1990s
Ross, R. (1993) · Nature · doi:10.1038/362801a0 · Cited by 10,630
The L-Arginine-Nitric Oxide Pathway
Epstein, F. H., Moncada, S., & Higgs, A. (1993) · New England Journal of Medicine · doi:10.1056/nejm199312303292706 · Cited by 6,678
Blood pressure, stroke, and coronary heart disease
Collins, R., Peto, R., MacMahon, S., Godwin, J., Qizilbash, N., Collins, R., MacMahon, S., Hebert, P., Eberlein, K. A., Taylor, J. O., et al. (1990) · The Lancet · doi:10.1016/0140-6736(90)90944-z · Cited by 4,491
Apolipoprotein E: Cholesterol Transport Protein with Expanding Role in Cell Biology
Mahley, R. W. (1988) · Science · doi:10.1126/science.3283935 · Cited by 4,028
Spontaneous Hypercholesterolemia and Arterial Lesions in Mice Lacking Apolipoprotein E
Zhang, S. H., Reddick, R. L., Piedrahita, J. A., & Maeda, N. (1992) · Science · doi:10.1126/science.1411543 · Cited by 2,237
Self-citationHypertension in mice lacking the gene for endothelial nitric oxide synthase
Huang, P. L., Huang, Z., Mashimo, H., Bloch, K. D., Moskowitz, M. A., Bevan, J. A., & Fishman, M. C. (1995) · Nature · doi:10.1038/377239a0 · Cited by 2,070
MacMicking, J. D., Nathan, C., Hom, G., Chartrain, N., Fletcher, D. S., Trumbauer, M., Stevens, K., Xie, Q.-W., Sokol, K., Hutchinson, N., et al. (1995) · Cell · doi:10.1016/0092-8674(95)90085-3 · Cited by 1,444
Cardiovascular Medicine at the Turn of the Millennium: Triumphs, Concerns, and Opportunities
Braunwald, E. (1997) · New England Journal of Medicine · doi:10.1056/nejm199711063371906 · Cited by 1,424
LIPID NEPHROTOXICITY IN CHRONIC PROGRESSIVE GLOMERULAR AND TUBULO-INTERSTITIAL DISEASE
Moorhead, J. F., El-Nahas, M., Chan, M. K., & Varghese, Z. (1982) · The Lancet · doi:10.1016/s0140-6736(82)91513-6 · Cited by 1,070
Mancini, G. B. J., Henry, G. C., Macaya, C., O'Neill, B. J., Pucillo, A. L., Carere, R. G., Wargovich, T. J., Mudra, H., Lu¨scher, T. F., Klibaner, M. I., et al. (1996) · Circulation · doi:10.1161/01.cir.94.3.258 · Cited by 1,057
Elevated blood pressures in mice lacking endothelial nitric oxide synthase
Shesely, E. G., Maeda, N., Kim, H.-S., Desai, K. M., Krege, J. H., Laubach, V. E., Sherman, P. A., Sessa, W. C., & Smithies, O. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.23.13176 · Cited by 914
Self-citationDirect evidence for the importance of endothelium-derived nitric oxide in vascular remodeling.
Rudic, R. D., Shesely, E. G., Maeda, N., Smithies, O., Segal, S. S., & Sessa, W. C. (1998) · Journal of Clinical Investigation · doi:10.1172/jci1699 · Cited by 821
Self-citationChronic inhibition of nitric oxide synthesis. A new model of arterial hypertension.
Ribeiro, M. O., Antunes, E., de Nucci, G., Lovisolo, S. M., & Zatz, R. (1992) · Hypertension · doi:10.1161/01.hyp.20.3.298 · Cited by 786
Alexander, R. W. (1995) · Hypertension · doi:10.1161/01.hyp.25.2.155 · Cited by 785
Baylis, C., Mitruka, B., & Deng, A. (1992) · Journal of Clinical Investigation · doi:10.1172/jci115849 · Cited by 729
Nitric oxide and its role in the cardiovascular system
Loscalzo, J., & Welch, G. (1995) · Progress in Cardiovascular Diseases · doi:10.1016/s0033-0620(05)80001-5 · Cited by 602
A Noninvasive Computerized Tail-Cuff System for Measuring Blood Pressure in Mice
Krege, J. H., Hodgin, J. B., Hagaman, J. R., & Smithies, O. (1995) · Hypertension · doi:10.1161/01.hyp.25.5.1111 · Cited by 587
Self-citationMice lacking inducible nitric oxide synthase are not resistant to lipopolysaccharide-induced death.
Laubach, V. E., Shesely, E. G., Smithies, O., & Sherman, P. A. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.23.10688 · Cited by 580
Self-citationThe Role of Fluid Mechanics in the Localization and Detection of Atherosclerosis
Giddens, D. P., Zarins, C. K., & Glagov, S. (1993) · Journal of Biomechanical Engineering · doi:10.1115/1.2895545 · Cited by 490
Atherosclerosis impairs flow-mediated dilation of coronary arteries in humans.
Cox, D. A., Vita, J. A., Treasure, C. B., Fish, R. D., Alexander, R. W., Ganz, P., & Selwyn, A. P. (1989) · Circulation · doi:10.1161/01.cir.80.3.458 · Cited by 414
Antiatherogenic effect of captopril in the Watanabe heritable hyperlipidemic rabbit.
Chobanian, A. V., Haudenschild, C. C., Nickerson, C., & Drago, R. (1990) · Hypertension · doi:10.1161/01.hyp.15.3.327 · Cited by 411
Kaplan, J. R., Manuck, S. B., Adams, M. R., Weingand, K. W., & Clarkson, T. B. (1987) · Circulation · doi:10.1161/01.cir.76.6.1364 · Cited by 266
Vascular Endothelium, Hemodynamic Forces, and Atherogenesis
Gimbrone, M. A. (1999) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)65090-0 · Cited by 260
Zhang, S. H., Reddick, R. L., Burkey, B., & Maeda, N. (1994) · Journal of Clinical Investigation · doi:10.1172/jci117460 · Cited by 244
Self-citationEffects of hypertension and dyslipidemia on the decline in renal function
Mänttäri, M., Tiula, E., Alikoski, T., & Manninen, V. (1995) · Hypertension · doi:10.1161/01.hyp.26.4.670 · Cited by 229
Ischemic renal diseases: New insights into old entities
Meyrier, A., Hill, G. S., & Simon, P. (1998) · Kidney International · doi:10.1046/j.1523-1755.1998.00968.x · Cited by 182
Exacerbation of Atherosclerosis by Hypertension: Potential Mechanisms and Clinical Implications
Chobanian, A. V., & Alexander, R. D. (1996) · Archives of Internal Medicine · doi:10.1001/archinte.1996.00440160064009 · Cited by 176
de la Salud, O. M. (1999) · Revista cubana de higiene y epidemiología · Cited by 171
Keidar, S., Attias, J., Smith, J. D., Breslow, J. L., & Hayek, T. (1997) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1997.6844 · Cited by 141
Antiatherosclerotic and Antioxidative Effects of Captopril in Apolipoprotein E-Deficient Mice
Hayek, T., Attias, J., Smith, J. D., Breslow, J. L., & Keidar, S. (1998) · Journal of Cardiovascular Pharmacology · doi:10.1097/00005344-199804000-00011 · Cited by 108
Kowala, M. C., Grove, R. I., & Åberg, G. (1994) · Atherosclerosis · doi:10.1016/0021-9150(94)90037-x · Cited by 98
Esaki, T., Hayashi, T., Muto, E., Yamada, K., Kuzuya, M., & Iguchi, A. (1997) · Atherosclerosis · doi:10.1016/s0021-9150(96)05976-x · Cited by 90
Angiotensin-converting enzyme inhibitors and kidney protection: the AIPRI trial
Maschio, G., Alberti, D., Locatelli, F., Mann, J. F. E., Motolese, M., Ponticelli, C., Ritz, E., Janin, G., & Zucchelli, P. (1999) · Journal of Cardiovascular Pharmacology · doi:10.1097/00005344-199900001-00004 · Cited by 77
Behr‐Roussel, D., Rupin, A., Fabiani, J., & Verbeuren, T. J. (1999) · Atherosclerosis · doi:10.1016/s0021-9150(98)00254-8 · Cited by 63
Sugiyama, F., Haraoka, S., Watanabe, T., Shiota, N., Taniguchi, K., Ueno, Y., Tanimoto, K., Murakami, K., Fukamizu, A., & YAGAMI, K.-I. (1997) · PubMed · Cited by 60
Generation of a Polyclonal Antibody Against Lipid Peroxide-Modified Proteins
Kim, J. G., Sabbagh, F., Santanam, N., Wilcox, J. N., Medford, R. M., & Parthasarathy, S. (1997) · Free Radical Biology and Medicine · doi:10.1016/s0891-5849(96)00615-6 · Cited by 59
Elhage, R., Bayard, F., Richard, V. J., Holvoet, P., Duverger, N., Fiévet, C., & Arnal, J. (1997) · Circulation · doi:10.1161/01.cir.96.9.3048 · Cited by 56
Interstitial foam cells and oxidized lipoprotein in human glomerular disease.
Ab, M. (1999) · PubMed · Cited by 55
Antioxidant power of angiotensin‐converting enzyme inhibitors in vitro
Benzie, I. F. F., & Tomlinson, B. (1998) · British Journal of Clinical Pharmacology · doi:10.1046/j.1365-2125.1998.00664.x · Cited by 52
Nifedipine Prevents Renal Injury in Rats With Chronic Nitric Oxide Inhibition
Ribeiro, M. O., Antunes, E., Muscará, M. N., Nucci, G. D., & Zatz, R. (1995) · Hypertension · doi:10.1161/01.hyp.26.1.150 · Cited by 32
Gibbons, G. H. (1997) · Clinical Cardiology · doi:10.1002/j.1932-8737.1997.tb00008.x · Cited by 23
Type 3 hyperlipoproteinemia with mesangial foam cells in renal glomeruli.
Amatruda, J. M., Margolis, S., & Gm, H. (1974) · PubMed · Cited by 18
Cited by
Lusis, A. J. (2000) · Nature · doi:10.1038/35025203 · Cited by 4,839
Glass, C. K., & Witztum, J. L. (2001) · Cell · doi:10.1016/s0092-8674(01)00238-0 · Cited by 3,051
Cytokines in Atherosclerosis: Pathogenic and Regulatory Pathways
Tedgui, A., & Mallat, Z. (2006) · Physiological Reviews · doi:10.1152/physrev.00024.2005 · Cited by 1,701
Mouse Models of Diabetic Nephropathy
Brosius, F. C., Alpers, C. E., Bottinger, E. P., Breyer, M. D., Coffman, T. M., Gurley, S. B., Harris, R. C., Kakoki, M., Kretzler, M., Leiter, E. H., et al. (2009) · Journal of the American Society of Nephrology · doi:10.1681/asn.2009070721 · Cited by 895
Self-citationKLF2 Is a Novel Transcriptional Regulator of Endothelial Proinflammatory Activation
SenBanerjee, S., Lin, Z., Atkins, G. B., Greif, D. M., Rao, R. M., Kumar, A., Feinberg, M. W., Chen, Z., Simon, D. I., Luscinskas, F. W., et al. (2004) · The Journal of Experimental Medicine · doi:10.1084/jem.20031132 · Cited by 723
Metadata
- Authors
- Knowles, J. W., Reddick, R. L., Jennette, J. C., Shesely, E. G., Smithies, O., & Maeda, N.
- Venue
- Journal of Clinical Investigation
- Published
- 2000-02-15
- Volume
- 105
- Issue
- 4
- Pages
- 451-458
- ISSN
- 0021-9738 (ISSN-L)
- OpenAlex
- W2091430270
- Cited by
- 305
- References
- 43
- FWCI
- 11.53
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.